Stocks sell off - what I am looking at
Stocks sell off, with an update on SMC and other ideas.
Stocks sell off, with an update on SMC and other ideas.
@yenoms One of us! One of us!! $VNO Pref Gang
I bought a slug of $FCX today
AppLovin’s e-commerce advertiser base doubled to 22,061 stores since August, lifting CPMs roughly 46% as more products monetize previously…
Natera grew Q3 revenue 34% to $794 million, raised 2026 guidance to $3.005 billion to $3.035 billion, and named oncology head Solomon…
Intuit’s $3.68 billion Mailchimp sale removes a noncore unit as TurboTax shifts to assisted filing and Credit Karma faces volume pressure.
Netflix’s WWE deal pairs 52 weeks of programming with its ad-supported tier, while Peter Rice takes over content amid layoffs and Bela…
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
Qualcomm’s Q4 FY2026 review assesses its semiconductor business, moat, financials and valuation amid a chip-sector rebound.
Intuit shares fell 9.8% after chatbots slowed Credit Karma, while QuickBooks grew mid-teens and FY27 guidance stayed unchanged.
BKV · long BKV Corp, public for less than two years, is an underfollowed natural-gas producer pursuing early-stage projects and a transition.
TSOH Weekly Roundup covers Walmart’s soft U.S. comps and rapid delivery, Qiaodan’s challenge to Nike in China, and Suno’s AI-generated…
Palantir’s revenue rose 93% to $1.94 billion as U.S. commercial bookings jumped 149%, lifting GAAP operating margin to 47% and free cash…
Intercontinental Exchange combines high-margin exchanges, recurring data services and mortgage technology, trading at about 18 times 2027…
Modine's leaked database identifies Google behind a $4 billion agreement and $4.5 billion of additional demand, with nearly $15 billion of…
Adobe investment case summary.
Deere raised net income and cash flow guidance despite a 10% Production and Precision Ag sales decline, as construction and small-ag…
IRhythm’s ZEUS clearance cuts clinician review time 50%, targeting $100 million in five-year savings as cardiac monitoring margins expand…
Real Brokerage’s RE/MAX acquisition would triple its agent count, diversify revenue with franchise fees and expand share during a weak U.S.
Corcept Therapeutics expects Lifyorli and Korlym to support 44% revenue growth, while FDA and European decisions on relacorilant could…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.